PHARMACEUTICAL COMPOSITION OF 1-ADAMANTYLETHYLOXY-3-MORPHOLINO-2-PROPANOL OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR THE TREATMENT OF CEREBROVASCULAR DISEASE AND NEURODEGENERATIVE DISEASES OF THE CENTRAL NERVOUS SYSTEM

摘要

A pharmaceutical composition for parenteral use comprising the active substance 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof within the concentration range of 3-100 mg/ml for treatment of cerebrovascular pathology.